Selexipag (ACT-293987) in Pulmonary Arterial Hypertension

Clinical trial NCT01106014 · COMPLETED

Trial details

NCT number: NCT01106014
Sponsor: Actelion
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2009-12-01
Primary completion: 2014-04-01
Enrollment: 1156

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.